In Vitro Diagnostics Market Worth $144.7 Billion by 2027– Exclusive Report by MarketsandMarkets™
In November 2022, Thermo Fisher Scientific (US) launched the rapid RT-PCR Accula Flu A/Flu B Test designed to enable healthcare providers to detect and differentiate influenza A and B in about 30 minutes
View full press release